Home›Chemical pages without ChemSpiderID›Ropeginterferon alfa-2b🌐中文EnglishDeutschEspañolPortuguêsالعربية中文MedicationQ99754007· pop 7· linked from 46 articlesRopeginterferon alfa-2bAlso known as Besremipharmaceutical drugClinical Trials20 registeredPHASE2/PHASE3UNKNOWNClinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With ComorbiditiesNational Taiwan University Hospital · NCT05808322PHASE2UNKNOWNRopeginterferon Alfa 2b for Early MyelofibrosisThe University of Hong Kong · NCT04988815PHASE2NOT_YET_RECRUITINGRopeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic LeukemiaJonsson Comprehensive Cancer Center · NCT07468916PHASE3ACTIVE_NOT_RECRUITINGAvailable in 7 languagesEspañolDeutsch中文PortuguêsالعربيةOdiavia Wikidata sitelinks · CC0Connectionstumor necrosis factorProteinColony stimulating factor 2Proteininterleukin-1 familyCategoriesChemical pages without ChemSpiderIDDrug has EMA linkDrugs with non-standard legal statusImmunostimulantsInfobox drug articles without a structure imageOrphan drugsSource attribution